propafenone has been researched along with Drug Withdrawal Symptoms in 2 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schüppel, R | 1 |
| Probst, M | 1 |
| Vincenti, A | 1 |
| Landolina, M | 1 |
| Latini, R | 1 |
| Cavalli, A | 1 |
| Gaita, F | 1 |
| Giani, P | 1 |
1 trial available for propafenone and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Washout of long-term treatment with flecainide and propafenone in patients with complex ventricular arrhythmias and cardiac disease. Antiarrhythmic Drug Evaluation Group.
Topics: Arrhythmias, Cardiac; Electrocardiography; Flecainide; Heart Diseases; Humans; Male; Middle Aged; Pr | 1992 |
1 other study available for propafenone and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Acute cholestatic hepatitis and the sudden rise of the pacing threshold 5 weeks after VVI-pacemaker implantation.
Topics: Acute Disease; Aged; Cardiac Pacing, Artificial; Cholestasis; Electrocardiography; Hepatitis; Humans | 1994 |